Unpacking the Latest Options Trading Trends in Regeneron Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Investors have shown a predominantly bearish stance on Regeneron Pharmaceuticals (NASDAQ:REGN), as evidenced by recent options trading activity. Benzinga's options scanner revealed 9 unusual trades, with a sentiment split of 11% bullish and 88% bearish. The trades focus on a price range between $690 and $965. The company, known for its products in eye disease, cardiovascular disease, cancer, and inflammation, has seen its stock price slightly decrease by -0.03% to $958.71. Analyst ratings in the last 30 days have set an average price target of $1137.25 for REGN.
March 15, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals has seen a bearish sentiment from options traders, with a significant focus on puts over calls. Despite this, analyst ratings remain optimistic with an average price target of $1137.25.
The bearish sentiment from options traders, indicated by the predominance of puts and the specific price range targeted, suggests a short-term negative outlook for REGN's stock price. However, the optimism from analysts, as reflected in their price targets, indicates a potential rebound or positive correction in the medium to long term. The slight decrease in stock price and the bearish options trading activity are likely to influence short-term investor sentiment negatively.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100